Published in Women's Health Weekly, November 18th, 1996
The studies, published in the November 6, 1996, issue of the Journal of the National Cancer Institute, found that women who took tamoxifen for five years after early breast cancer surgery had about an 18 percent better chance of surviving without relapse than patients who did not take the drug.
One study showed that taking the drug for longer than five years conferred no survival advantage and could risk other disorders.
Experts praised the studies as...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly